Oethmaan Biosims is a pharmaceutical company fully owned by individuals of black ethnicity, aiming to oversee the complete value chain of making affordable and easily accessible drugs available to the wider community of South Africa. Since October 2016, we have commenced the necessary regulatory adjustments mandated by the MCC to update the dossier information, enabling the launch of products under the new company name. These updates are currently underway, with anticipation for the imminent approval of the initial product and scheduled product launch in August 2017.